Clinical Trial Update: Semaglutide (Wegovy) Treatment for Trichotillomania [Phase 2]

View source ↗

Summary

A Phase 2 trial update shows semaglutide (Wegovy) is being studied for trichotillomania (hair-pulling disorder) and is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Trichotillomania

Drugs mentioned

• WEGOVY (Semaglutide)

Snippet

Sponsor: University of Chicago | Conditions: Trichotillomania (Hair-Pulling Disorder), Trichotillomania | Phase 2 | Status: NOT_YET_RECRUITING